{'fraction_non_alphanumeric': 0.015202702702702704, 'fraction_numerical': 0.011824324324324325, 'mean_word_length': 5.376344086021505, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
An Analytical Study of Foreign Direct Investment In Pharma Sector of India

India liberalized its FDI policies in 2005, to allow up to a 100% FDI stake in ventures across the diverse sectors. It has substantially reduced industrial licensing requirements, removed restrictions on expansion and facilitated easy access to foreign technology and foreign direct investment FDI. Keeping in mind the increased importance of FDI and favorable changes in domestic system (legal and administrative), researcher in this research article has analysed the development and status of FDI in pharma sector.